Skip to content

Clinical trials

Recruiting Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Recruiting Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20172
20181
20192
20203
20213
20226
20237
202412
20259
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic5
National Cancer Institute (NCI)4
City of Hope Medical Center3
M.D. Anderson Cancer Center2
Alentis Therapeutics AG1
Astellas Pharma Global Development, Inc.1
Beth Israel Deaconess Medical Center1
Bold Therapeutics, Inc.1
DualityBio Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma62
Carcinoma, Hepatocellular14
Colorectal Neoplasms13
Biliary Tract Neoplasms10
Liver Neoplasms10
Pancreatic Neoplasms10
Stomach Neoplasms9
Breast Neoplasms8
Ovarian Neoplasms8
Carcinoma, Non-Small-Cell Lung7

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.